ArticleAnnals of surgical oncology2023

RAS Mutation Status Should Not Be Used to Predict Outcome from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases.

Dilraj Bhullar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.